SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-038595
Filing Date
2020-02-14
Accepted
2020-02-14 17:16:02
Documents
8
Period of Report
2020-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889175d8k.htm 8-K 24133
2 EX-1.1 d889175dex11.htm EX-1.1 190574
3 EX-5.1 d889175dex51.htm EX-5.1 6738
4 EX-99.1 d889175dex991.htm EX-99.1 14935
5 EX-99.2 d889175dex992.htm EX-99.2 15464
6 GRAPHIC g889175g0214221727546.jpg GRAPHIC 2836
7 GRAPHIC g889175g0214222551480.jpg GRAPHIC 2569
8 GRAPHIC g889175g0214223010196.jpg GRAPHIC 2569
  Complete submission text file 0001193125-20-038595.txt   264550
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 20621923
SIC: 2834 Pharmaceutical Preparations